Brief: Alligator Bioscience AB - Q3 Operating Result at Sek -30.6 mln
22/10/2020 07:17
Oct 22 (Reuters) - Alligator Bioscience AB ATORX.ST :
* ALLIGATOR BIOSCIENCE AB - Q3 NET SALES, SEK 0.0 MILLION (4.3)
* ALLIGATOR BIOSCIENCE AB - Q3 OPERATING RESULT, SEK -30.6 MILLION (-58.5)
* ALLIGATOR BIOSCIENCE AB - PHASE I CLINICAL STUDY PROCEEDS WITH THE AIM TO PRESENT RESULTS
IN
2021
Source text for Eikon: ID:nWkrR2q2y
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln